University of Oklahoma, Health Science Center

Oklahoma City, Oklahoma 79104

7 studies enrolling now · 48 studies all time

What they study most

Acute Coronary Syndrome, Acute Ischemic Stroke, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Acute Stroke, Angioplasty, Transluminal, Percutaneous Coronary, Arterial Occlusive Diseases, Atopic Dermatitis, Atrial Fibrillation, Autoimmune Diseases, Berger Disease, Bergers Disease

Studies at this site

• Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN — Recruiting now
• Continuous Dual Aspiration Technique With Zoom System for Stroke — Recruiting now
• A Study of Sigvotatug Vedotin in Advanced Solid Tumors — Recruiting now
• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
• Combination of TATE and PD-1 Inhibitor in Liver Cancer — Recruiting now
• MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels — Recruiting now
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. — Running, not enrolling
• Dual Versus Single Shock for Cardioversion of Atrial Fibrillation — Stopped early
• A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor — Running, not enrolling
• Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study ) — Stopped early
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• REal-World Analyses of Stroke - Thrombus Occlusion REtrieval — Completed
• A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer — Stopped early
• A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer — Completed
• JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis — Completed
• Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma — NO_LONGER_AVAILABLE
• Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules — Completed
• Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU — Completed
• JetStream Atherectomy for the Treatment of In-stent Restenosis — Completed
• TODAY2 Phase 2 Follow-up — Completed
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) — Completed
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL — Withdrawn before enrolling
• PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer — Completed
• Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed
• Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter — Completed
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• Antibiotic Safety (SCAMP) — Completed
• Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites — Completed
• Micra Transcatheter Pacing System Continued Access Study Protocol — Completed
• Cost Analysis for Endoscopic Retrograde Cholangiopancreatography (ERCP) — Withdrawn before enrolling
• Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA — Completed
• Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 — Available (expanded access)
• TAXUS Libertē Post Approval Study — Completed
• EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries — Completed
• Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer — Status unconfirmed
• Management of Superficial Thrombophlebitis — Completed
• Treatment of Upper Extremity Deep-Vein Thrombosis — Completed
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis — Paused
• Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety — Completed
• Percent Body Fat in Breast Fed Infants — Completed
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed
• Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma — Stopped early
• St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder. — Completed
• PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen — Status unconfirmed
• Trial of VLTS-589 in Subjects With Intermittent Claudication — Completed